Hyperthermic intraoperative chemotherapy (HIOC) for Stage IVa thymic malignancy may improve 5‐year disease‐free survival
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.27150
Abstract: Stage IVa thymic malignancy has limited treatments. This study evaluated whether hyperthermic intraoperative chemotherapy (HIOC) after radical resection of Stage IVa thymic malignancy improves survival. read more here.
Keywords: hyperthermic intraoperative; stage iva; thymic malignancy; iva thymic ... See more keywords